SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

Neurology
​Trends

Vascular and inflammatory markers of dementia.

1/29/2020

0 Comments

 
Picture
Increasing evidence over the last 20 years has shown us that hemostatic abnormalities (either a propensity for bleeding or clotting) are not only important in vascular dementia, but also in patients with Alzheimer's dementia. And we know that there is tremendous crossover in these dementia types. Of all the hemostatic markers, serum fibrinogen has been the one most commonly studied.  
All in all, while this article does reinforce much of what we know from Dr. Dale Bredesen's teachings, I believe too that modification and control of serum markers of hypercoagulability along with markers of systemic inflammation such as CRP and homocysteine among others, can offer a preventive approach to Alzheimer’s, often labeled “the most dreaded disease in America.”

A hypercoagulable workup would include protein C, protein S, antithrombin, Factor VIII, PT PTT, Lupus anticoagulant, CBC, Factor V Leiden and fibrinogen.

We must as physicians ask if everyone needs these labs when we already have some so many other positive inflammatory markers. Unless you are also evaluating the neurology patient for a history of TIAs or stroke, I don’t believe these may be necessary. Despite being an often-preventable tragedy, in the U.S. alone we know that strokes are occurring virtually every 40 seconds. If an MRI shows significant white matter pathology, in the conventional neurology world, we would likely do a full vascular evaluation and take a thorough history, get a carotid ultrasound or magnetic resonance angiography, echocardiogram etc.  And in the integrative world, I believe we should do this as well…along with a deep dive into root causes in selected cases where this discovery process is appropriate.

Looking at the markers and labs available to us that may indicate cognitive disease, this is indeed a complicated area of diagnosis and treatment.  But also knowing what we know now, through the work of colleagues like Dr. Bredesen, we can clearly see why patients that have had a stroke also have a higher risk of developing dementia. It should be our mission to use this information to help these and other patients with the widest range of resources available to us that includes sound integrative medicine protocols.

In health,
Dr. Suzy Gazda

For more about strokes and facts you should know, please visit: https://www.cdc.gov/stroke/facts.htm

Read more about the ARIC (Atherosclerosis Risk in Communities) cohort study at:
https://n.neurology.org/content/92/11/e1256
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Author

    Dr. Suzanne Gazda, Integrative Neurology

    Archives

    December 2022
    November 2022
    September 2022
    April 2022
    November 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019

    Categories

    All

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

baguillon@nisatx.com
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact